DK1623019T3 - Begrænset glucosetilførsel til dyrecellekultur - Google Patents

Begrænset glucosetilførsel til dyrecellekultur

Info

Publication number
DK1623019T3
DK1623019T3 DK04752591.0T DK04752591T DK1623019T3 DK 1623019 T3 DK1623019 T3 DK 1623019T3 DK 04752591 T DK04752591 T DK 04752591T DK 1623019 T3 DK1623019 T3 DK 1623019T3
Authority
DK
Denmark
Prior art keywords
glucose
cell culture
feeding
restricted
rate
Prior art date
Application number
DK04752591.0T
Other languages
English (en)
Other versions
DK1623019T4 (da
Inventor
Denis Drapeau
Terry Cardoza Stanek
Yen-Tung Luan
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33476770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1623019(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of DK1623019T3 publication Critical patent/DK1623019T3/da
Application granted granted Critical
Publication of DK1623019T4 publication Critical patent/DK1623019T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04752591.0T 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur DK1623019T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47093703P 2003-05-15 2003-05-15
PCT/US2004/015597 WO2004104186A1 (en) 2003-05-15 2004-05-17 Restricted glucose feed for animal cell culture

Publications (2)

Publication Number Publication Date
DK1623019T3 true DK1623019T3 (da) 2010-09-27
DK1623019T4 DK1623019T4 (da) 2017-03-27

Family

ID=33476770

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04752591.0T DK1623019T4 (da) 2003-05-15 2004-05-17 Begrænset glucosetilførsel til dyrecellekultur

Country Status (10)

Country Link
US (1) US7429491B2 (da)
EP (1) EP1623019B2 (da)
AT (1) ATE472597T2 (da)
DE (1) DE602004027905D1 (da)
DK (1) DK1623019T4 (da)
ES (1) ES2344789T5 (da)
PL (1) PL1623019T5 (da)
PT (1) PT1623019E (da)
SI (1) SI1623019T1 (da)
WO (1) WO2004104186A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103276033A (zh) 2006-09-13 2013-09-04 雅培制药有限公司 细胞培养改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
WO2008036600A2 (en) * 2006-09-18 2008-03-27 Genentech, Inc. Methods of protein production
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
US20090042253A1 (en) * 2007-08-09 2009-02-12 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
SI2310523T1 (sl) * 2008-04-17 2015-10-30 Wyeth Llc Postopki za boljšo proizvodnjo kostnih morfogenetskih proteinov
WO2010016943A2 (en) 2008-08-08 2010-02-11 Biogen Idec Ma Inc. Nutrient monitoring and feedback control for increased bioproduct production
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
CN105111309A (zh) * 2008-10-20 2015-12-02 Abbvie公司 使用a蛋白亲和层析分离和纯化抗体
ES2622366T3 (es) 2009-10-26 2017-07-06 F. Hoffmann-La Roche Ag Procedimiento para la producción de una inmunoglobulina glucosilada
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2012147048A2 (en) 2011-04-29 2012-11-01 Biocon Research Limited Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
AU2013309506A1 (en) 2012-09-02 2015-03-12 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014144999A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Use of raman spectroscopy to monitor culture medium
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
CA2913687C (en) 2013-07-04 2022-12-13 F. Hoffmann-La Roche Ag Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
EA201991976A1 (ru) 2013-10-11 2020-04-02 Регенерон Фармасьютикалз, Инк. Метаболически оптимизированная клеточная культура
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
EP3119876B1 (en) 2014-03-19 2024-12-18 Pfizer Inc. Method of cell culture
EP3164481A4 (en) 2014-07-02 2018-03-21 Biogen MA Inc. Cross-scale modeling of bioreactor cultures using raman spectroscopy
US20180291329A1 (en) * 2015-05-29 2018-10-11 Biogen Ma Inc. Cell culture methods and systems
US11597903B2 (en) 2015-05-29 2023-03-07 Boehringer Ingelheim International Gmbh Cell-controlled perfusion in continuous culture
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法（一）
ES2989780T3 (es) 2015-09-23 2024-11-27 Pfizer Células y procedimiento de cultivo celular
CA3056011A1 (en) 2017-03-14 2018-09-20 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN111954719B (zh) 2018-03-26 2025-07-18 美国安进公司 细胞培养物中产生的抗体的总去岩藻糖基化糖型
EA202092684A1 (ru) 2018-08-27 2021-03-11 Ридженерон Фармасьютикалз, Инк. Применение рамановской спектроскопии для последующей очистки
SG11202104092UA (en) 2018-11-13 2021-05-28 Janssen Biotech Inc Control of trace metals during production of anti-cd38 antibodies
US20220073942A1 (en) 2018-12-06 2022-03-10 Pfizer Inc. Cells with reduced inhibitor production and methods of use thereof
AU2020368466A1 (en) * 2019-10-18 2022-05-12 Janssen Biotech, Inc. Dynamic monosaccharide control processes
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
KR20230058094A (ko) 2020-08-31 2023-05-02 리제너론 파아마슈티컬스, 인크. 세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략
JP2022060169A (ja) * 2020-10-02 2022-04-14 ファイザー・インク Ｒｓｖ ｆタンパク質生産のための細胞培養工程
JP2024503408A (ja) 2021-01-20 2024-01-25 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 細胞培養におけるタンパク質力価の改善方法
IL311248A (en) 2021-10-07 2024-05-01 Regeneron Pharma PH meter calibration and repair
TW202323817A (zh) 2021-10-07 2023-06-16 美商再生元醫藥公司 Ｐｈ建模及控制之系統及方法
WO2023167855A1 (en) 2022-03-02 2023-09-07 Regeneron Pharmaceuticals, Inc. Manufacturing process for high titer antibody
US20240010709A1 (en) 2022-05-25 2024-01-11 Genentech, Inc. Methods for preparing mammalian cells for perfusion cell culture
WO2024218706A1 (en) 2023-04-21 2024-10-24 Pfizer Inc. Improved cells and cell cultures
WO2025088516A1 (en) 2023-10-26 2025-05-01 Pfizer Inc. Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product including multi-specific antibodies thus obtained

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631142A (en) * 1986-07-01 1997-05-20 Genetics Institute, Inc. Compositions comprising bone morphogenetic protein-2 (BMP-2)
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5506117A (en) * 1989-10-18 1996-04-09 Cytokinetics, Inc. Biochemical process for growing living cells by measuring the amount of nutrient added to the reaction medium
US5346826A (en) * 1989-10-18 1994-09-13 Andrews Franklin T Process for conducting biochemical reactions
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5856179A (en) * 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
WO1998041611A1 (en) * 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US6531464B1 (en) * 1999-12-07 2003-03-11 Inotek Pharmaceutical Corporation Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
EP1404813A4 (en) * 2001-06-13 2004-11-24 Genentech Inc METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS
DE10255508A1 (de) * 2002-11-27 2004-06-17 Forschungszentrum Jülich GmbH Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen

Also Published As

Publication number Publication date
DE602004027905D1 (de) 2010-08-12
SI1623019T1 (sl) 2010-10-29
PT1623019E (pt) 2010-07-20
EP1623019A1 (en) 2006-02-08
WO2004104186A1 (en) 2004-12-02
ES2344789T3 (es) 2010-09-07
US20050070013A1 (en) 2005-03-31
DK1623019T4 (da) 2017-03-27
PL1623019T5 (pl) 2018-02-28
US7429491B2 (en) 2008-09-30
EP1623019B1 (en) 2010-06-30
ES2344789T5 (es) 2017-06-14
PL1623019T3 (pl) 2010-10-29
EP1623019B2 (en) 2017-01-25
ATE472597T2 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
DK1623019T3 (da) Begrænset glucosetilførsel til dyrecellekultur
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
JP2010110331A5 (da)
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
WO2008136398A1 (ja) 高濃度アミノ酸含有培地を用いた細胞の培養方法
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
DE60336548D1 (de) Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins
PL377603A1 (pl) Poprawa jakości produktu w hodowlach komórek ssaczych do wytwarzania białka
ATE412761T1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
ATE342958T1 (de) Verbessertes rollflaschesystem zur kultivierung von zellen und gewebe
WO2005028626A3 (en) Cell culture media
EP4406615A3 (en) Method for the production of a glycosylated immunoglobulin
AU2003255309A1 (en) Method and device for culturing cells
HRP20070474T3 (en) Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
CN102268402B (zh) 无血清培养基及cho细胞中高效表达促红素的培养方法
DE60307615D1 (de) Zellkulturmedium
Koebmann et al. The extent to which ATP demand controls the glycolytic flux depends strongly on the organism and conditions for growth
Jee et al. Influence of redox potential on methanation of methanol by Methanosarcina barkeri in Eh-stat batch cultures
DE60123397D1 (de) Methode zur erhöhung der fermentationsgeschwindigkeit von hefe
WO2006031840A3 (en) Increasing the stability of recombinant adult human apohemoglobin
Altamirano et al. Galactose and lactate as nutrients in continuous cultures of CHO cells producing rh-tPA
DK1246909T3 (da) Fremgangsmåde til fremstilling af hydroxynitril-lyaser
Hackbarth et al. Monitoring and quantification of bioelectrochemical biofilms by means of OCT in novel and customized reactor-setups
Le Bec Spatiotemporal control of cooperation in yeast communities
Luo et al. Regeneration of Astragalus adsurgens via somatic embryogenesis from cell suspension protoplasts.